Additionally, topiramate may interfere with GLP-1's glucose-lowering effects, reducing overall efficacy for diabetes-related weight loss
How can we prioritise this being a health thing rather than a money-making thing? Not a quick fix NICE chose a two-year maximum window for a person to take semaglutide for weight loss for two reasons first, because that fits with NHS tier 3 and 4 services and, second, because that was the model Novo Nordisk presented in line with current trial evidence
Schuler MH, Di Bartolomeo F, Mrtensson CU, Daum G, Becker T (2016) Phosphatidylcholine affects inner membrane protein translocases of mitochondria
For research-protocol design, the practical implication is that dual- and triple-agonist compounds are not interchangeable with stacks of single-agonist components
Exploring Treatment Options Semaglutide may be an option for some non-diabetics seeking medical support for weight loss, but the best treatment approach depends on your health history, goals, and eligibility
But then things got better